Literature DB >> 9335443

Diabetes mellitus and the risk of primary liver cancer.

C La Vecchia1, E Negri, A Decarli, S Franceschi.   

Abstract

The relationship between diabetes mellitus and primary liver cancer was investigated in a case-control study conducted in Italy between 1984 and 1996 on 428 cases with incident, histologically confirmed hepatocellular carcinoma, 59 with gallbladder and bile duct cancer, and 1,502 control subjects in the hospital for acute non-neoplastic diseases. Sixty-four cases of hepatocellular carcinoma vs. 87 controls reported a history of diabetes, corresponding to an odds ratio (OR) of 2.3 after allowance for age, sex and area of residence, and of 2.1 [95% confidence interval (CI) = 1.4-3.2] after further allowance for alcohol and tobacco consumption, history of hepatitis and liver cirrhosis, body mass index and history of liver cancer in first-degree relatives. The ORs were similar both for subjects diagnosed with diabetes below age 45, who most likely had insulin-dependent diabetes, and for those diagnosed later, who were likelier to have non-insulin-dependent diabetes. The OR was 2.3 for subjects whose diabetes was diagnosed <5 years before diagnosis of liver cancer, 1.9 for those diagnosed 5-9 years in advance and 2.2 for those diagnosed since 10 years or more. Five cases of gallbladder and bile duct cancer reported a history of diabetes: the corresponding OR was 1.2 (95% CI 0.5-2.9). The OR of hepatocellular carcinoma was 2.4 for males and 2.0 for females, 3.0 for subjects diagnosed with liver cancer under age 60 and 1.8 for those diagnosed at age 60 or over. None of the other covariates considered, including education, history of hepatitis, liver cirrhosis and alcohol drinking showed any meaningful modifying effect or interaction. The potential pathogenic mechanisms include liver alteration-and consequent cell proliferation-in subjects with diabetes. Thus a history of diabetes mellitus could explain about 8% (95% CI 5-11) of cases of liver cancer in this population.

Entities:  

Mesh:

Year:  1997        PMID: 9335443     DOI: 10.1002/(sici)1097-0215(19971009)73:2<204::aid-ijc7>3.0.co;2-#

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  27 in total

1.  Pre-operative factors that can predict neoplastic polypoid lesions of the gallbladder.

Authors:  Byung Hyo Cha; Jin-Hyeok Hwang; Sang Hyub Lee; Jang Eon Kim; Jai Young Cho; Haeryoung Kim; So Yeon Kim
Journal:  World J Gastroenterol       Date:  2011-05-07       Impact factor: 5.742

2.  Diabetes mellitus as a risk factor for gastrointestinal cancers among postmenopausal women.

Authors:  Juhua Luo; Rowan Chlebowski; Simin Liu; Katherine A McGlynn; Niyati Parekh; Donna L White; Karen L Margolis
Journal:  Cancer Causes Control       Date:  2012-05-24       Impact factor: 2.506

3.  Patients with Diabetes Mellitus are Prone to Develop Severe Hepatitis and Liver Failure due to Hepatitis Virus Infection.

Authors:  Kumar K Singh; Subrat K Panda; Subrat K Acharya
Journal:  J Clin Exp Hepatol       Date:  2013-11-23

4.  Diabetes is associated with increased perioperative mortality but equivalent long-term outcome after hepatic resection for colorectal cancer.

Authors:  Sarah A Little; William R Jarnagin; Ronald P DeMatteo; Leslie H Blumgart; Yuman Fong
Journal:  J Gastrointest Surg       Date:  2002 Jan-Feb       Impact factor: 3.452

5.  Diabetes mellitus impairs the response to intra-arterial chemotherapy in hepatocellular carcinoma.

Authors:  Yin-Hsun Feng; Cheng-Yao Lin; Wen-Tsung Huang; Chia-Ling Wu; Jui-Lung Fang; Chao-Jung Tsao
Journal:  Med Oncol       Date:  2010-08-24       Impact factor: 3.064

6.  Clinical features and prognosis in patients with hepatocellular carcinoma that developed after hepatitis C virus eradication with interferon therapy.

Authors:  Yuko Nagaoki; Hiroshi Aikata; Daisuke Miyaki; Eisuke Murakami; Yoshimasa Hashimoto; Yoshio Katamura; Takahiro Azakami; Tomokazu Kawaoka; Shintaro Takaki; Akira Hiramatsu; Koji Waki; Michio Imamura; Yoshiiku Kawakami; Shoichi Takahashi; Kazuaki Chayama
Journal:  J Gastroenterol       Date:  2011-03-04       Impact factor: 7.527

7.  Dietary glycemic load, glycemic index, and carbohydrates on the risk of primary liver cancer among Chinese women and men.

Authors:  E Vogtmann; H L Li; X O Shu; W H Chow; B T Ji; H Cai; J Gao; W Zhang; Y T Gao; W Zheng; Y B Xiang
Journal:  Ann Oncol       Date:  2012-08-16       Impact factor: 32.976

Review 8.  Diabetes and cancer I: risk, survival, and implications for screening.

Authors:  Adedayo A Onitilo; Jessica M Engel; Ingrid Glurich; Rachel V Stankowski; Gail M Williams; Suhail A Doi
Journal:  Cancer Causes Control       Date:  2012-05-03       Impact factor: 2.506

Review 9.  Diabetes mellitus and metformin in hepatocellular carcinoma.

Authors:  Koji Fujita; Hisakazu Iwama; Hisaaki Miyoshi; Joji Tani; Kyoko Oura; Tomoko Tadokoro; Teppei Sakamoto; Takako Nomura; Asahiro Morishita; Hirohito Yoneyama; Tsutomu Masaki
Journal:  World J Gastroenterol       Date:  2016-07-21       Impact factor: 5.742

10.  Concurrent hyperglycemia does not influence the long-term prognosis of unresectable hepatocellular carcinomas.

Authors:  Xiao-Ping Li; Zhen Chen; Zhi-Qiang Meng; Wen-Xia Huang; Lu-Ming Liu
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.